Kawasaki-like syndrome linked to COVID-19 in children is a new condition

A study on children suffering from severe inflammatory symptoms shows the condition is new and distinct from Kawasaki disease. In April, researchers in the UK and several European countries with high numbers of COVID-19 cases recognised a new inflammatory syndrome in children that was similar to Kawasaki disease, a rare syndrome known to affect young […]

Read More… from Kawasaki-like syndrome linked to COVID-19 in children is a new condition

Bacterial co-infections & antimicrobial resistance

bacteria

Researchers identify the impact of bacterial co-infections and antimicrobial resistance in COVID-19 A team of researchers from Queen’s University Belfast have identified new problems linked to the disease and warn of a sharp rise in antimicrobial resistance associated to COVID-19 treatments in the aftermath of the pandemic. In their paper, published in EMBO Molecular Medicine, […]

Read More… from Bacterial co-infections & antimicrobial resistance

Imperial social enterprise to accelerate low-cost COVID-19 vaccine

vaccine

Imperial College London has formed a new social enterprise VacEquity Global Health (VGH) to bring its COVID-19 vaccine to the world. For the UK and low-income countries abroad, Imperial and VGH will waive royalties and charge only modest cost-plus prices to sustain the enterprise’s work, accelerate global distribution and support new research. The social enterprise’s […]

Read More… from Imperial social enterprise to accelerate low-cost COVID-19 vaccine

Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership

vaccines

The Vaccines Manufacturing and Innovation Centre (VMIC), a not-for-profit organisation established to provide the UK’s first strategic vaccine development and advanced manufacturing capability has signed its first industry partnership agreement with gene and cell therapy group Oxford Biomedica plc. The agreement signed today involves the organisations collaborating to enable scaled-up manufacture of viral vector based […]

Read More… from Vaccines Manufacturing and Innovation Centre Signs First Industry Partnership

RSM webinar series for trainees on the frontline

The Royal Society of Medicine and the Health Education Kent Surrey Sussex (HEKSS) Deanery, are hosting a new webinar series for all trainees working in frontline medicine. This two-part series will provide case-based scenarios covering the most common acute medical presentations, including cardiology, respiratory, neurology and acute medicine. Experts in their fields, our panel of […]

Read More… from RSM webinar series for trainees on the frontline

Use of antiepileptic drugs with Alzheimer’s warning

Antiepileptic drugs are associated with a higher risk of mortality in persons with Alzheimer’s disease. The use of antiepileptic drugs is associated with a higher risk of death among persons with Alzheimer’s disease, according to a new study from the University of Eastern Finland. The results were published in Neurology. The mortality risk increased considerably during […]

Read More… from Use of antiepileptic drugs with Alzheimer’s warning

ECMO Proto Device fights Covid-19

Shandong University Researchers Develop ECMO Proto Device in Aid of Fighting COVID-19. After the COVID-19 outbreak, the name ECMO (Extracorporeal Membrane Oxygenation) has caught the eyes of the public. Regarded as the last resort to save severe COVID-19 patients, ECMO is used to sustain breathing for patients with severe cardio-pulmonary failure by providing continuous extracorporeal […]

Read More… from ECMO Proto Device fights Covid-19

Feasibility of genetic screening for prostate cancer

genetics

Feasibility of genetic screening for prostate cancer   Genetic ‘barcoding’ in GP surgeries picks out men at increased risk for follow-up checks   Pilot study shows population screening is feasible for improving disease detection   Larger-scale study to begin which could prove effectiveness of a prostate cancer screening programme Genetic screening for prostate cancer in […]

Read More… from Feasibility of genetic screening for prostate cancer

Over half of smokers in England want to quit for COVID

smokers

Over half (53%) of current smokers with lung conditions were planning to quit smoking due to COVID -19 in May, finds survey by Asthma UK and the British Lung Foundation. New evidence suggests that over half of smokers in England living with lung conditions want to ‘Quit for Covid’. The number of people with lung […]

Read More… from Over half of smokers in England want to quit for COVID